BioNTech SE is 15.6x more valuable than Immunocore Holdings plc by market capitalization ($22.18 B vs $1.42 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMCR | BNTX |
|---|---|---|
| Market cap | $1.42 B | $22.18 B |
| US-listed rank | #2368 | #582 |
| Revenue (latest FY) | $400.02M | - |
| Net income (latest FY) | -$35.51M | - |
| Net margin | -8.9% | - |
| SEC filings | 265 | 548 |
BioNTech SE is 15.6x more valuable than Immunocore Holdings plc by market capitalization ($22.18 B vs $1.42 B).
Full pages: Immunocore Holdings plc and BioNTech SE, or browse the full rankings.